What is the current protein assays market size?

The protein assays market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the protein assays market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the protein assays market?

Increasing demand for biotechnology research and growing need for disease diagnosis drive the market.

What are the major challenges faced by the protein assays market?

High cost of assays and lack of skilled professionals are significant challenges.

Which regions are leading the protein assays market?

North America and Europe are leading due to advanced research infrastructure.

Who are the top companies in the protein assays market?

Top companies include Thermo Fisher, Bio-Rad, and Merck, offering a range of assay products.

What are the future opportunities in the protein assays market?

Emerging economies and increasing proteomics research present future opportunities.

How does technology impact the protein assays market?

Advances in technology such as microfluidics and automation enhance assay efficiency and accuracy.

What is the current regulatory landscape for protein assays?

Stringent regulations and standards from FDA and EU agencies ensure assay quality and safety.

What is the future outlook for the protein assays market?

The market is expected to grow significantly due to increasing demand for protein-based research.

Which Companies Lead the protein assays Market in 2026?

protein assays by Application (Pharmaceuticals, Disease Diagnosis, Others), by Types (Dye-Binding Assays, Copper-Ion-Based Assays, Test Strip-Based Assays, Others) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

protein assays Market Size | CAGR 10.2 Forecast 2033

Which Companies Lead the protein assays Market in 2026?

protein assays by Application (Pharmaceuticals, Disease Diagnosis, Others), by Types (Dye-Binding Assays, Copper-Ion-Based Assays, Test Strip-Based Assays, Others) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

protein assays Market Overview

The protein assays market refers to the industry involved in the development and distribution of assays used to detect and quantify proteins in various samples. As a crucial component of life science research, the protein assays market size is estimated to be around $1.8 billion. The growth outlook for the protein assays market is promising, with a market forecast expecting significant expansion during the forecast period. The industry expansion is driven by factors such as increasing demand for protein-based therapies, growing research in proteomics, and rising investments in life science research. The scope of the protein assays market encompasses various types of assays, including enzyme-linked immunosorbent assay (ELISA), western blotting, and mass spectrometry, among others.

Loading chart…

The protein assays market is expected to grow at a compound annual growth rate (CAGR) of around 10% during the forecast period. The growth is driven by macro drivers such as increasing investments in life science research, growing demand for protein-based therapies, and rising awareness about proteomics research. Key forces shaping the industry include technology shifts towards more sensitive and accurate assays, regulations supporting the development of new therapies, and competitive intensity among market players. The largest region in the protein assays market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to witness significant expansion during the forecast period, driven by the increasing demand for protein assays in various applications, including biotechnology, pharmaceuticals, and academic research.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; Promega Corporation; GE Healthcare; Perkinelmer, Inc.; Geno Technology, Inc.; Cell Signaling Technology, Inc.; Abcam PLC.; Novus Biologicals, LLC; Soltec Ventures (Soltec Bio Science); Lonza Group; Biovision Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The protein assays market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in protein assays technology are enhancing the accuracy and efficiency of protein quantification, leading to increased adoption across research and diagnostic applications, thereby contributing to the growth of the protein assays market size.

The expanding scope of proteomics research, fueled by government initiatives and funding, is driving the demand for protein assays, further bolstering the growth forecast of the market.

Restraints2 items

High costs associated with protein assays and the requirement for specialized equipment and expertise are limiting their accessibility, particularly in resource-constrained settings, which can hinder the growth of the protein assays market.

Stringent regulatory frameworks governing the use of protein assays in clinical diagnostics can impede the pace of innovation and market penetration, affecting the overall protein assays market size.

Opportunities2 items

The emerging trend of personalized medicine creates new opportunities for protein assays in targeted therapy development, enabling more precise diagnosis and treatment monitoring, and thus, expanding the protein assays market.

Collaborations between industry players and research institutions can accelerate the development of novel protein assays, addressing unmet needs in disease diagnosis and treatment, and contributing to a positive growth forecast.

Challenges2 items

Ensuring the reproducibility and standardization of protein assays results across different laboratories and platforms remains a significant challenge, impacting the reliability and comparability of data, and affecting the protein assays market size.

The protein assays market faces competition from alternative technologies, such as genomics and metabolomics, which can offer complementary or, in some cases, superior insights into biological processes, influencing the market's growth forecast.

Market Segmentation

Loading chart…

The protein assays market can be segmented based on application, which includes research and development, diagnostics, quality control, and other applications. Each of these segments contributes to the overall protein assays market size, with research and development accounting for the largest share due to the increasing demand for protein-based therapies and diagnostic tests. Understanding the protein assays segmentation is crucial for industry players to identify opportunities and trends in the market.

Another way to segment the protein assays market is by types, which includes Western blot, ELISA, mass spectrometry, and other types. Each of these types has its own strengths and weaknesses, and their adoption varies depending on the application and industry. For instance, ELISA is widely used in diagnostic applications due to its high sensitivity and specificity, while mass spectrometry is commonly used in research and development due to its ability to provide detailed information about protein structure and function. Analyzing the market taxonomy of protein assays by type helps to identify areas of growth and opportunities for innovation.

protein assays Segmentation Breakdown9 items

Application

Pharmaceuticals

Disease Diagnosis

Others

Types

Dye-Binding Assays

Copper-Ion-Based Assays

Test Strip-Based Assays

Others

Regional Insights

Loading chart…

The protein assays market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of protein assays in research and development, favorable policies, and significant investments in the life sciences sector.

Key drivers in North America include a mature ecosystem, high infrastructure development, and a large patient pool. In Europe, drivers include a strong regulatory framework, increasing demographics with a growing aging population, and a high demand for protein assays in research institutions. Asia Pacific's growth is driven by a large and growing population, increasing adoption of protein assays, and significant investments in the life sciences sector. Latin America's growth is driven by increasing infrastructure development and a growing demand for protein assays. Middle East & Africa's growth is driven by increasing adoption and a growing demand for protein assays in research institutions.

The regional forecast indicates that Asia Pacific will experience the highest protein assays market growth, driven by increasing demand and adoption of protein assays. The region's large and growing population, combined with significant investments in the life sciences sector, will drive growth in the protein assays market.

Competitive Landscape

The protein assays market is moderately consolidated, driven by a mix of global players and local/regional companies. The protein assays competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and localization to gain a competitive edge.

Companies in the protein assays market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players focus on strategic initiatives to mitigate these challenges and maintain their market position.

Bio-Rad Laboratories, Inc. - regional expansion

Thermo Fisher Scientific Inc. - innovation pipeline

Merck KGaA - premium pricing

Promega Corporation - OEM tie-ups

GE Healthcare - vertical integration

Perkinelmer, Inc. - local manufacturing

Key protein assays Companies13 items

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Merck KGaA

Promega Corporation

GE Healthcare

Perkinelmer, Inc.

Geno Technology, Inc.

Cell Signaling Technology, Inc.

Abcam PLC.

Novus Biologicals, LLC

Soltec Ventures (Soltec Bio Science)

Lonza Group

Biovision Inc.

Market Ecosystem

The protein assays ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and consumed. Value is created and captured at each stage, with technology providers, manufacturers, and distributors playing critical roles in the protein assays ecosystem.

Raw material suppliers — provide essential components

Technology providers — develop assay technologies

OEMs / manufacturers — produce protein assay products

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance

End users / buyers — utilize protein assays in research and diagnostics

Regulators/standards bodies — establish guidelines and standards

In the protein assays ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the approval and adoption of new technologies. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of protein assay products. Furthermore, switching costs and partnerships can be significant, as end users often require customized solutions and may be locked into specific technologies or platforms. A thorough value chain analysis is necessary to understand these dynamics and identify potential bottlenecks in the protein assays ecosystem.

Recent Industry Insights

The protein assays industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships, such as collaborations between key players, have enhanced research and development capabilities, driving innovation in the sector. Notable mergers and acquisitions have also led to the expansion of product portfolios and strengthened market positions.

Furthermore, the launch of new products and technologies has improved assay sensitivity and specificity, addressing the growing demand for accurate and reliable protein quantification. Regulatory changes have also influenced the industry, with updated guidelines emphasizing the need for standardized protocols and quality control measures. As a result, the protein assays market is expected to experience steady growth, driven by increasing demand from biotechnology and pharmaceutical companies.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the protein assays market outlook. The market attractiveness is high due to increasing demand for protein assays in research and development, driven by advancements in biotechnology and pharmaceutical industries. Competitive intensity is moderate, with key players focusing on innovation and strategic partnerships to gain market share.

The long-term outlook for the protein assays market is positive, with a growing need for accurate and efficient protein quantification methods. The innovation landscape is characterized by the development of novel assay technologies, such as label-free detection methods. However, demand-supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions.

11 items

1. Executive Summary

2. protein assays Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global protein assays Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global protein assays Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceuticals

6.1.2. Disease Diagnosis

6.1.3. Others

6.2. Global protein assays Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Dye-Binding Assays

6.2.2. Copper-Ion-Based Assays

6.2.3. Test Strip-Based Assays

6.2.4. Others

6.3. Global protein assays Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global protein assays Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global protein assays Market by: Regions (Value)

8. Global protein assays Market Competition by Key Manufacturers

8.1. Global protein assays Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global protein assays: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bio-Rad Laboratories, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck KGaA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Promega Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GE Healthcare

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Perkinelmer, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Geno Technology, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cell Signaling Technology, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abcam PLC.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Novus Biologicals, LLC

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Soltec Ventures (Soltec Bio Science)

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Lonza Group

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Biovision Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global protein assays Market

Figure 4: Global protein assays Market: Drivers

Figure 5: Global protein assays Market: Challenges

Figure 6: Global protein assays Market: Trends

Figure 7: Global protein assays Market: Opportunity

Figure 8: Global protein assays Market: Restraint

Figure 9: Global protein assays Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global protein assays Market Value (USD Million) By Region

Figure 15: Global protein assays Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global protein assays Market Value (USD Million) By Region

Figure 23: Global protein assays Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global protein assays Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global protein assays Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global protein assays Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global protein assays Market Value (USD Million) By Region

Table 10: Global protein assays Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global protein assays Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global protein assays Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global protein assays Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 31: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 32: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 33: Thermo Fisher Scientific Inc.. Products Portfolio

Table 34: Merck KGaA Basic Information And Sales Area

Table 35: Merck KGaA. Products Portfolio

Table 36: Promega Corporation Basic Information And Sales Area

Table 37: Promega Corporation. Products Portfolio

Table 38: GE Healthcare Basic Information And Sales Area

Table 39: GE Healthcare. Products Portfolio

Table 40: Perkinelmer, Inc. Basic Information And Sales Area

Table 41: Perkinelmer, Inc.. Products Portfolio

Table 42: Geno Technology, Inc. Basic Information And Sales Area

Table 43: Geno Technology, Inc.. Products Portfolio

Table 44: Cell Signaling Technology, Inc. Basic Information And Sales Area

Table 45: Cell Signaling Technology, Inc.. Products Portfolio

Table 46: Abcam PLC. Basic Information And Sales Area

Table 47: Abcam PLC.. Products Portfolio

Table 48: Novus Biologicals, LLC Basic Information And Sales Area

Table 49: Novus Biologicals, LLC. Products Portfolio

Table 50: Soltec Ventures (Soltec Bio Science) Basic Information And Sales Area

Table 51: Soltec Ventures (Soltec Bio Science). Products Portfolio

Table 52: Lonza Group Basic Information And Sales Area

Table 53: Lonza Group. Products Portfolio

Table 54: Biovision Inc. Basic Information And Sales Area

Table 55: Biovision Inc.. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global protein assays Market Value (USD Million) By Region

Table 61: Global protein assays Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

protein assays Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; Promega Corporation; GE Healthcare; Perkinelmer, Inc.; Geno Technology, Inc.; Cell Signaling Technology, Inc.; Abcam PLC.; Novus Biologicals, LLC; Soltec Ventures (Soltec Bio Science); Lonza Group; Biovision Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options